期刊
MEDICAL HYPOTHESES
卷 71, 期 4, 页码 527-529出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.mehy.2008.06.010
关键词
-
资金
- Basic and Clinical Medicine cross-disciplinary Research Foundation
- Shanghai Medical College of Fudan University [2007JL01]
- Scientific research start-up foundation for Young major scientists of Shanghai Medical College of Fudan University [2007L02]
Renal cell carcinoma (RCC) remains a difficult management problem, because of the high metastatic rate and insensitivity of metastatic RCC to the traditional cytokine-based immunotherapy such as interleukin-2 and interferon-alpha. Regulatory T cells had a crucial role in impeding immune surveillance against cancer and hampering the development of effective anti-tumor immunity. At the same time cyclooxygenase-2 derived prostaglandin E-2 played an important role in the transformation of regulatory T cells and could strengthen the inhibitory function of regulatory T cells. Previous experiment characterized that cyclooxygenase-2 was highly expressed in RCC. Herein, we draw the hypothesis that cyclooxygenase-2 inhibition may dampen the transformation of regulatory T cells and in turn contribute to eradicating RCC by the immune system. The clinical application of cyclooxygenase-2 inhibitors may strengthen the sensitivity of RCC to cytokine-based immunotherapy. (c) 2008 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据